Overexpression of p53 protein in Barrett's syndrome with malignant transformation

J Clin Pathol. 1993 Apr;46(4):330-3. doi: 10.1136/jcp.46.4.330.

Abstract

Aims: To study the overexpression of p53 protein in Barrett's oesophagus with adenocarcinoma, and to correlate this expression with the pathological features of Barrett's syndrome.

Methods: Immunohistochemical staining was performed on frozen sections with a monoclonal antibody directed against wild type and mutated p53 protein (Pab 1801). Eleven cases of Barrett's adenocarcinoma were studied, seven of which had extensive sampling of benign Barrett's mucosa.

Results: Eight of 11 adenocarcinomas overexpressed the p53 protein. Both early and advanced tumours were positive. In Barrett's mucosa around the p53 positive tumours, high grade dysplasia was positive; low grade dysplasia and non-dysplastic mucosa were negative.

Conclusions: P53 gene mutation with ensuing p53 protein overexpression is a common feature of Barrett's adenocarcinoma, both at early and advanced stages. This mutation appears as a relatively late event during the neoplastic transformation of Barrett's oesophagus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / chemistry*
  • Adenocarcinoma / genetics
  • Adenocarcinoma / pathology
  • Aged
  • Aged, 80 and over
  • Barrett Esophagus* / genetics
  • Barrett Esophagus* / pathology
  • Esophageal Neoplasms / chemistry*
  • Esophageal Neoplasms / genetics
  • Esophageal Neoplasms / pathology
  • Esophagus / pathology
  • Gene Expression / physiology
  • Genes, p53
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Tumor Suppressor Protein p53 / analysis*

Substances

  • Tumor Suppressor Protein p53